Antibacterial agents in preclinical and clinical development
The Lancet Microbe · 2024
DOI: 10.1016/j.lanmic.2024.100962 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Lancet Microbe, 2024. Verfasst von Timothy Jesudason. Hauptthemen laut MEDLINE: Anti-Bacterial Agents, Drug Development. Die Arbeit wurde bisher 17-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
On June 14, 2024, WHO published a global report on antibacterial agents in preclinical and clinical development. The resource provides an update to the WHO antibacterial pipeline analysis report in 2022 and includes both traditional and non-traditional antibacterial agents currently in development worldwide.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Zitieren
APA
Jesudason, T. (2024). Antibacterial agents in preclinical and clinical development. The Lancet Microbe. https://doi.org/10.1016/j.lanmic.2024.100962
Vancouver
Jesudason T. Antibacterial agents in preclinical and clinical development. The Lancet Microbe. 2024. doi:10.1016/j.lanmic.2024.100962
BibTeX
@article{Jesudason2024,
author = {Jesudason, Timothy},
title = {Antibacterial agents in preclinical and clinical development},
journal = {The Lancet Microbe},
year = {2024},
doi = {10.1016/j.lanmic.2024.100962}
}
EUVIMED